4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.99 +0.53 (+4.25%)
At close: Nov 11, 2026 · 4:00 PM EST

4D Molecular Therapeutics (FDMT) Return on Assets [ROA] (2021 - 2026)

Updated

4D Molecular Therapeutics' Return on Assets [ROA] was -35.60% in Q2 2026, up 4.05 percentage points from -39.65% a year earlier but down 5.81 percentage points from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at 4D Molecular Therapeutics came in at -24.86%, up 10.87 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +7.76 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -35.72% in FY2024 (-2.27 pp), -33.46% in FY2023 (+1.47 pp), -34.93% in FY2022 (-12.74 pp) and -22.19% in FY2021 (+10.43 pp).
  • Quarterly Return on Assets [ROA] has moved between -46.60% (Q3 2025) and -17.55% (Q2 2024) over five years.
  • Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -5.71 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2024 (a gain of 21.90 percentage points); the worst was Q3 2025 (a drop of 23.17 percentage points).
  • Per Business Quant data, FDMT's Return on Assets [ROA] in the three quarters before Q2 2026 was -29.79% (Q1 2026), -28.28% (Q4 2025) and -46.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 4D Molecular Therapeutics 875.59 Mn -584.35 Mn - -35.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.60%
Mar 31, 2026 -29.79%
Dec 31, 2025 -28.28%
Sep 30, 2025 -46.60%
Jun 30, 2025 -39.65%
Mar 31, 2025 -32.79%
Dec 31, 2024 -27.62%
Sep 30, 2024 -23.43%
Jun 30, 2024 -17.55%
Mar 31, 2024 -21.53%
Dec 31, 2023 -28.70%
Sep 30, 2023 -26.82%
Jun 30, 2023 -37.34%
Mar 31, 2023 -43.42%
Dec 31, 2022 -39.65%
Sep 30, 2022 -36.07%
Jun 30, 2022 -32.39%
Mar 31, 2022 -23.93%
Dec 31, 2021 -23.97%
Sep 30, 2021 -26.85%
API Access

4D Molecular Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEY